17Aug
UK Life Sciences and Healthcare Newsletter - August 2020: COVID-19 – How Have Listed Companies Fared?
COVID-19 has had a significant financial impact on many listed companies and, in recent months, there has been a marked increase in equity capital raises by listed companies. As at 22 July 2020, there have been over 100 secondary equity fundraisings in excess of £10 million on the Main Market and AIM since the COVID lockdown period began. Some have had to raise emergency capital, on short notice and often at significant discounts, whereas others have sought to shore up their balance sheets as...
By:
Dechert LLP
Related
On April 15, 2019, the Indiana Court of Appeals issued a ruling that significantly developed restric...
Read More >
The government and market response to the COVID-19 pandemic is presenting novel and difficult legal ...
Read More >
The novel coronavirus (COVID-19) has implications for multiple workplace concerns, including health ...
Read More >
Iowa’s five Medical Cannabidiol (described within this article as “medical marijuana”) dispensari...
Read More >
On November 22nd, the CFPB issued a press release announcing that a stipulated final judgment and or...
Read More >
Whether contemplating an acquisition or assessing strategic alternatives, there are many aspects of ...
Read More >